Remarkably, by the induction of Uncoupling Protein 1, tofacitinib induced the phenomenon of adipocyte browning and/or the emergence of brown-like adipocytes in white adipose depots with consequent relevant metabolic benefits in the treatment of the metabolic diseases [23]. The gene discussed is UCP1; the disease is Other metabolic disease.